Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 6 (2009), Issue 1 (January)

1. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages.
   Blood, 113(2): 438-46. [Abstract] [Full-text]
2. Preparing for adulthood: health care transition counseling for youth with arthritis.
   Arthritis Rheum, 61(1): 52-7. [Abstract] [Full-text]
3. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
   Arthritis Rheum, 61(1): 46-51. [Abstract] [Full-text]
4. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
   Arthritis Rheum, 61(1): 4-12. [Abstract] [Full-text]
5. Does damage cause inflammation? Revisiting the link between joint damage and inflammation.
   Ann Rheum Dis, 68(2): 159-62. [Abstract] [Full-text]
6. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease.
   Ann Rheum Dis, 68(2): 279-82. [Abstract] [Full-text]
7. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents.
   Ann Rheum Dis, 68(2): 249-52. [Abstract] [Full-text]
8. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
   Ann Rheum Dis, 68(2): 242-5. [Abstract] [Full-text]
9. Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies.
   Ann Rheum Dis, 68(2): 222-7. [Abstract] [Full-text]
10. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Ann Rheum Dis, 68(2): 201-8. [Abstract] [Full-text]
11. Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis.
    Ann Rheum Dis, 68(2): 264-72. [Abstract] [Full-text]
12. Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.
    Ann Rheum Dis, 68(2): 216-21. [Abstract] [Full-text]
13. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
    Ann Rheum Dis, 68(2): 209-15. [Abstract] [Full-text]
14. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review.
    Ann Rheum Dis, 68(2): 183-90. [Abstract] [Full-text]
15. The arthropathy of Down syndrome: an underdiagnosed and under-recognized condition.
    J Pediatr, 154(2): 234-8. [Abstract] [Full-text]
16. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Vaccine, 27(5): 690-700. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.